Biosyent investor
http://www.biosyent.com/rx/investors_financials/ WebNov 17, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that …
Biosyent investor
Did you know?
http://www.biosyent.com/rx/investor_center/ WebAug 23, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and are subject to risks and uncertainties that may cause actual results or outcomes to be …
WebApr 14, 2024 · René Goehrum, President and CEO of BioSyent, will present to investors an overview of BioSyent’s business and corporate activities on April 21 at 11:00 am. Mr. Goehrum will also be available to ... WebSep 29, 2024 · BioSyent climbed a long way after the early 2024 pandemic pullback. The stock went from about $3.20 to $8.00 before the year was out. But 2024 has been a bit of a bust so far, with the stock ...
WebMar 21, 2024 · MISSISSAUGA, Ontario, March 21, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and … WebDec 23, 2004 · Globe Investor - The Globe and Mail - Wed Apr 12, 4:02PM CDT. Today, shares of Biosyent Inc opened at $7.45 and closed at $7.70. ... Biosyent Inc is a TSX Drug Specialty & Generic company ...
WebMar 31, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and are subject to risks and uncertainties that may cause actual results or outcomes to be …
WebMar 9, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are forward-looking. The contents herein ... how do i switch profiles in dtsWebNov 15, 2012 · TORONTO, ONTARIO--(Marketwire - Nov 15, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its Third Quarter (Q3) 2012 financial results. - Q3 2012 Sales of $1,575,598 sets an all time quarterly record and grew by 60% over Q3 2011 how much oas do i get when i turn 65WebSep 14, 2024 · René Goehrum, President and CEO of BioSyent, will present to investors an overview of BioSyent’s business and corporate activities. The MicroCap Leadership Summit is attended by retail and ... how much oas do you getWebOct 28, 2013 · BioSyent only has 13.5 million shares outstanding (14.5m FD), 43% controlled by the management and the board. BioSyent's CEO Rene Goehrum owns 18% of the company, and CFO Alfred D'Souza owns 11%. Mr. how do i switch profiles on kindle fireWebMar 21, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are … how do i switch phones on sprintWebMar 31, 2024 · For further information please contact: Mr. René C. Goehrum President and CEO BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and … how much oak chips to add to wineWebFeb 24, 2024 · 1.3% of BioSyent shares are held by institutional investors. 40.6% of BioSyent shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. how much oas will i get at 60